Deep learning as a staging tool in gastric cancer.

Authors :: De Paepe KN
Cunningham D
Source :: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2020 Jul; Vol. 31 (7), pp. 827-828. Date of Electronic Publication: 2020 May 08.
Publication Year :: 2020
Abstract: Competing Interests: Disclosure Professor Cunningham has declared research funding from Amgen, Sanofi, Merrimack, AstraZeneca, Celgene, MedImmune, Bayer, 4SC, Clovis, Eli Lilly, Janssen, and Merck. He has participated in the Scientific Advisory Board of OVBIO. Dr De Paepe has declared no conflicts of interest.

Subjects :: Deep Learning
Humans
Lymphatic Metastasis
Neoplasm Staging
Nomograms
Stomach Neoplasms pathology

Language :: English
ISSN :: 1569-8041
Volume :: 31
Issue :: 7
Database :: MEDLINE
Journal :: Annals of oncology : official journal of the European Society for Medical Oncology
Publication Type :: Editorial & Opinion
Accession number :: 32389797
Full Text :: https://doi.org/10.1016/j.annonc.2020.04.477